Enterprise IT vendor IBM on Wednesday announced its big data deal with Caris Life Sciences.
As per the deal, Caris Life Sciences will utilize IBM technical computing and storage technology to accelerate the company’s molecular profiling services for cancer patients.
Caris has developed a data-aware and secure infrastructure with IBM systems and servers for complex molecular profiling analysis.
Caris can make recommendations on 55 potentially actionable drug to molecular target associations to profile both genomic and proteomic data over the current 19 therapeutic recommendations using genomic information alone.
IBM Tivoli Storage Manager and code name Elastic Storage to its HPC environment enable Caris to access and process massive amounts of data at a significantly faster pace.
Frank N. Lee, lead architect, Genomic Medicine, IBM, said: “IBM technology has helped Caris handle this data volume with greater speed, efficiency and scalability, and at the same time maintain the required security and reliability essential for handling medical and health data.”